The Spanish Competition Authority authorizes the takeover of a medical equipment and supply manufacturer by a company that makes and sells medical devices related to urology and endocrinology (Coloplast / Atos)

Coloplast acquires control of Atos.* On 21 December 2021, the CNMC authorised the takeover of Atos

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.